Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Nanjing Reju Therapeutics Co., Ltd

Clinical trials sponsored by Nanjing Reju Therapeutics Co., Ltd, explained in plain language.

Not yet recruiting 2
Sort by
  • New eye ointment for dry eye passes first safety check

    Symptom relief Not yet recruiting

    This early-stage study tests whether a new eye ointment called RC017 is safe and tolerable in 24 healthy adults aged 18 to 55. The ointment is being developed to treat dry eye disease. Participants will receive either the ointment or a placebo, and researchers will monitor for si…

    Phase: PHASE1 • Sponsor: Nanjing Reju Therapeutics Co., Ltd • Aim: Symptom relief

    Last updated Jun 27, 2026 12:06 UTC

  • New inhaled drug for lung disease tested in healthy people first

    Knowledge-focused Not yet recruiting

    This early-stage study tests a new inhaled drug called RC010 in 42 healthy adults in China. The main goal is to check if it is safe and how the body processes it. This drug is being developed for a serious lung condition called idiopathic pulmonary fibrosis (IPF), but this study …

    Phase: PHASE1 • Sponsor: Nanjing Reju Therapeutics Co., Ltd • Aim: Knowledge-focused

    Last updated Jun 27, 2026 12:08 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space